Esperion Therapeutics
| Use attributes for filter ! | |
| Stock price | ESPR |
|---|---|
| Disclaimer | |
| Ceo | Tim Mayleben |
| Headquarters | Ann Arbor |
| Michigan | |
| United States | |
| Founded | 1998 |
| SVP | Ashley Hall |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844737 |
About Esperion Therapeutics
Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
